Forbes September 4, 2024
Arianna Johnson

Topline

A class of drugs that includes popular medications like Ozempic, Wegovy, Rybelsus (semaglutide) or Mounjaro and Zepbound (tirzepatide) has not only proven effective in treating weight loss and diabetes: Mounting evidence suggests these drugs may be effective at treating other conditions like cancer, Alzheimer’s and COVID-19.

Key Facts

Covid-19: Semaglutide (ozempic, Wegovy, Rybelsus) Could Impact Death Rate

Although patients taking semaglutide during the COVID-19 pandemic had similar rates of COVID-19 infection compared to the placebo group, those taking the drug had a 33% lower risk of dying from coronavirus infection, researchers found.

Cardiovascular Issues: Semaglutide Drugs May Reduce Strokes, Heart Attacks

An August study found semaglutide reduces the risk of developing cardiovascular conditions like stroke and heart attack in...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Pharma / Biotech
Pharma Pulse 11/25/24: Deepening Patient Relationships, Menopause May Increase Risk of Asthma & more
Axolotl Biosciences Brings Biotech to the Forefront at Formnext 2024
Innovative approach maps gene activity in the living human brain
Trump tariffs could drive up generic drug costs: 5 takeaways
Answer ALS, Cedars-Sinai Collaboration, Single-Cell Protein Profiling, ChapsVision Acquires Sinequa, More

Share This Article